Cabozantinib in Women With Metastatic Hormone-Receptor-Positive Breast Cancer

This study is currently recruiting participants.
Verified January 2013 by Massachusetts General Hospital
Sponsor:
Collaborator:
Exelixis
Information provided by (Responsible Party):
Michaela J. Higgins, Massachusetts General Hospital
ClinicalTrials.gov Identifier:
NCT01441947
First received: September 22, 2011
Last updated: January 15, 2013
Last verified: January 2013
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: December 2013
  Estimated Primary Completion Date: November 2013 (Final data collection date for primary outcome measure)